Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anteris Technologies Global (AVR) Gains from Investment Securities (2024 - 2026)

Anteris Technologies Global (AVR) reported Gains from Investment Securities of $941000.0 for Q1 2026, up 1233.73% on a QoQ basis from -$83000.0 in Q4 2025.

Anteris Technologies Global (AVR) has 3 years of Gains from Investment Securities data on file, last reported at $941000.0 in Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $941000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $776000.0 (changed N/A YoY) and the FY2025 annual result came in at $52750.0, down 68.59% from the prior year.
  • Gains from Investment Securities rose to $941000.0 in Q1 2026 per AVR's latest filing, from -$83000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $941000.0 in Q1 2026 and bottomed at -$86000.0 in Q4 2024.
  • The 3-year median for Gains from Investment Securities is $4000.0 (2024), against an average of $250200.0.
  • Peak annual rise in Gains from Investment Securities reached 3.49% in 2025, while the deepest fall reached 3.49% in 2025.
  • Tracing AVR's Gains from Investment Securities over 3 years: stood at -$86000.0 in 2024, then advanced by 3.49% to -$83000.0 in 2025, then surged by 1233.73% to $941000.0 in 2026.
  • Per Business Quant, the three latest AVR Gains from Investment Securities figures stand at $941000.0 (Q1 2026), -$83000.0 (Q4 2025), and -$86000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Anteris Technologies Global 753.31 Mn 753.28 Mn 380,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 941,000.00
Mar 31, 2026 941,000.00
Dec 31, 2025 -83,000.00
Dec 31, 2025 -83,000.00
Dec 31, 2024 -86,000.00
Dec 31, 2024 -86,000.00
Jun 30, 2024 475,000.00
Jun 30, 2024 475,000.00
Mar 31, 2024 4,000.00
Mar 31, 2024 4,000.00